Azd-7762

Azd-7762

SCHEMBL1564574

NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@@H]1CCCNC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHEK1

The experimentally established mechanism targets of Azd-7762. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 known ✓ O14757 18/20 1.00
▸ MELK Q14680 3/20 1.00
▸ PLK4 O00444 1/20 1.00
▸ GAK O14976 1/20 1.00
▸ JAK2 O60674 1/20 1.00
▸ ULK1 O75385 1/20 1.00
▸ RPS6KA4 O75676 1/20 1.00
▸ STK10 O94804 1/20 1.00
▸ PRKD3 O94806 1/20 1.00
▸ MAP4K4 O95819 1/20 1.00
▸ PAK4 O96013 1/20 1.00
▸ ABL1 P00519 1/20 1.00
▸ EGFR P00533 1/20 1.00
▸ LCK P06239 1/20 1.00
▸ FYN P06241 1/20 1.00
▸ FES P07332 1/20 1.00
▸ YES1 P07947 1/20 1.00
▸ LYN P07948 1/20 1.00
▸ RET P07949 1/20 1.00
▸ HCK P08631 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Azd-7762 SCHEMBL15105420 1.00 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL31517325 1.00 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL29388936 1.00 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL1127614 1.00 CHEK1 (1.00) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL29994838 0.99 MELK (1.00) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL19457662 0.99 MELK (1.00) CHEK1MELKPLK4GAKJAK2
SCHEMBL31532638 0.97 CHEK1 (0.95) CHEK1MELKPLK4GAKJAK2
SCHEMBL31532541 0.97 CHEK1 (0.95) CHEK1MELKPLK4GAKJAK2
Azd-7762 SCHEMBL1127337 0.96 CHEK1 (0.92) CHEK1MELKPLK4GAKJAK2
SCHEMBL31532639 0.94 CHEK1 (0.89) CHEK1MELKPLK4GAKJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025099238-A1 COMPOUNDS FOR USE IN THE TREATMENT OF GASTROINTESTINAL STROMAL TUMOR (GIST) Universität Duisburg-Essen (DE) 2025-05-15 — — WO disclosed
EP-4552639-A1 COMPOUNDS FOR USE IN THE TREATMENT OF GASTROINTESTINAL STROMAL TUMOR (GIST) Universität Duisburg-Essen (DE) 2025-05-14 — — EP disclosed
US-20210317107-A1 INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2021-10-14 — — US disclosed
US-10981896-B2 Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-04-20 — — US disclosed
EP-2305671-A1 Thiophene and thiazole derivatives as CHK1 inhibitors AstraZeneca AB (SE) 2011-04-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317107-A1 INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE MELK, HIPK1, HIPK3 CHEK1 252/4885MELK 1/4885PLK4 17/4885
US-10981896-B2 Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase MELK, HIPK1, HIPK3 CHEK1 310/4885MELK 1/4885PLK4 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback